Lack of genomic diversity in the SLC47A1 gene within the indigenous Xhosa population

References

1. Otsuka M, Matsumoto T, Morimoto R, Arioka S, Omote H, Moriyama Y. A human transporter protein that mediates the final excretion step for toxic organic cations. Proc Natl Acad Sci USA 2005;102:17923–8.10.1073/pnas.0506483102Search in Google Scholar PubMed PubMed Central

2. Staud F, Cerveny L, Ahmadimoghaddam D, Ceckova M. Multidrug and toxin extrusion proteins (MATE/SLC47); role in pharmacokinetics. Int J Biochem Cell Biol 2013;45:2007–11.10.1016/j.biocel.2013.06.022Search in Google Scholar PubMed

3. Masuda S, Terada T, Yonezawa A, Tanihara Y, Kishimoto K, Katsura T, et al. Identification and functional characterization of a new human kidney-specific H⁺/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2. J Am Soc Nephrol 2006;17:2127–35.10.1681/ASN.2006030205Search in Google Scholar PubMed

4. Tsuda M, Terada T, Asaka J-i, Ueba M, Katsura T, Inui K-i. Oppositely directed H⁺ gradient functions as a driving force of rat H⁺/organic cation antiporter MATE1. Am J Physiol Renal Physiol 2007;292:F593–8.10.1152/ajprenal.00312.2006Search in Google Scholar PubMed

5. Ahmadimoghaddam D, Zemankova L, Nachtigal P, Dolezelova E, Neumanova Z, Cerveny L, et al. Organic cation transporter 3 (OCT3/SLC22A3) and multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter in the placenta and fetal tissues: expression profile and fetus protective role at different stages of gestation 1. Biol Reprod 2013;88:55.10.1095/biolreprod.112.105064Search in Google Scholar PubMed

6. Komatsu T, Hiasa M, Miyaji T, Kanamoto T, Matsumoto T, Otsuka M, et al. Characterization of the human MATE2 proton-coupled polyspecific organic cation exporter. Int J Biochem Cell Biol 2011;43:913–8.10.1016/j.biocel.2011.03.005Search in Google Scholar PubMed

7. Tsuda M, Terada T, Mizuno T, Katsura T, Shimakura J, Inui K-i. Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin. Mol Pharmacol 2009;75:1280–6.10.1124/mol.109.056242Search in Google Scholar PubMed

8. Watanabe S, Tsuda M, Terada T, Katsura T, Inui K-i. Reduced renal clearance of a zwitterionic substrate cephalexin in MATE1-deficient mice. J Pharmacol Exp Ther 2010;334: 651–6.10.1124/jpet.110.169433Search in Google Scholar PubMed

9. Tanihara Y, Masuda S, Sato T, Katsura T, Ogawa O, Inui K-i. Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H⁺-organic cation antiporters. Biochem Pharmacol 2007;74:359–71.10.1016/j.bcp.2007.04.010Search in Google Scholar PubMed

10. Terada T, Masuda S, Asaka J-i, Tsuda M, Katsura T, Inui K-i. Molecular cloning, functional characterization and tissue distribution of rat H⁺/organic cation antiporter MATE1. Pharm Res 2006;23:1696–701.10.1007/s11095-006-9016-3Search in Google Scholar PubMed

11. Iwata K, Aizawa K, Kamitsu S, Jingami S, Fukunaga E, Yoshida M, et al. Effects of genetic variants in SLC22A2 organic cation transporter 2 and SLC47A1 multidrug and toxin extrusion 1 transporter on cisplatin-induced adverse events. Clin Exp Nephrol 2012;16:843–51.10.1007/s10157-012-0638-ySearch in Google Scholar PubMed

12. He X, Szewczyk P, Karyakin A, Evin M, Hong W-X, Zhang Q, et al. Structure of a cation-bound multidrug and toxic compound extrusion transporter. Nature 2010;467:991–4.10.1038/nature09408Search in Google Scholar PubMed PubMed Central

13. Zhang X, He X, Baker J, Tama F, Chang G, Wright SH. Twelve transmembrane helices form the functional core of mammalian MATE1 (multidrug and toxin extruder 1) protein. J Biol Chem 2012;287:27971–82.10.1074/jbc.M112.386979Search in Google Scholar PubMed PubMed Central

14. Zhang X, Wright SH. MATE1 has an external COOH terminus, consistent with a 13-helix topology. Am J Physiol Renal Physiol 2009;297:F263–71.10.1152/ajprenal.00123.2009Search in Google Scholar PubMed PubMed Central

15. Astorga B, Ekins S, Morales M, Wright SH. Molecular determinants of ligand selectivity for the human multidrug and toxin extruder proteins MATE1 and MATE2-K. J Pharmacol Exp Ther 2012;341:743–55.10.1124/jpet.112.191577Search in Google Scholar PubMed PubMed Central

16. Wittwer MB, Zur AA, Khuri N, Kido Y, Kosaka A, Zhang X, et al. Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling. J Med Chem 2013;56:781–95.10.1021/jm301302sSearch in Google Scholar PubMed PubMed Central

17. Gaowa A, Motohashi H, Katsura T, Inui K-i. Effects of metabolic acidosis on expression levels of renal drug transporters. Pharm Res 2011;28:1023–30.10.1007/s11095-010-0348-7Search in Google Scholar PubMed

18. Nishihara K, Masuda S, Ji L, Katsura T, Inui K-I. Pharmacokinetic significance of luminal multidrug and toxin extrusion 1 in chronic renal failure rats. Biochem Pharmacol 2007;73: 1482–90.10.1016/j.bcp.2006.12.034Search in Google Scholar PubMed

19. Becker ML, Visser LE, van Schaik RH, Hofman A, Uitterlinden AG, Stricker BH. Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study. Diabetes 2009;58:745–9.10.2337/db08-1028Search in Google Scholar PubMed PubMed Central

20. Choi JH, Yee SW, Kim MJ, Nguyen L, Lee JH, Kang J-O, et al. Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1. Pharmacogenet Genomics 2009;19:770–80.10.1097/FPC.0b013e328330eecaSearch in Google Scholar PubMed PubMed Central

21. Tsuda M, Terada T, Ueba M, Sato T, Masuda S, Katsura T, et al. Involvement of human multidrug and toxin extrusion 1 in the drug interaction between cimetidine and metformin in renal epithelial cells. J Pharmacol Exp Ther 2009;329: 185–91.10.1124/jpet.108.147918Search in Google Scholar

22. Ito S, Kusuhara H, Yokochi M, Toyoshima J, Inoue K, Yuasa H, et al. Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney. J Pharmacol Exp Ther 2012;340:393–403.10.1124/jpet.111.184986Search in Google Scholar

23. Grun B, Kiessling M, Burhenne J, Riedel K, Weiss J, Rauch G. Trimethoprim-metformin interaction and its genetic modulation by OCT2 and MATE1 transporters. Br J Clin Pharmacol 2013;76:787–96.10.1111/bcp.12079Search in Google Scholar

24. Ito S, Kusuhara H, Kuroiwa Y, Wu C, Moriyama Y, Inoue K, et al. Potent and specific inhibition of mMate1-mediated efflux of type I organic cations in the liver and kidney by pyrimethamine. J Pharmacol Exp Ther 2010;333:341–50.10.1124/jpet.109.163642Search in Google Scholar

25. Coovadia H, Jewkes R, Barron P, Sanders D, McIntyre D. The health and health system of South Africa: historical roots of current public health challenges. Lancet 2009;374:817–34.10.1016/S0140-6736(09)60951-XSearch in Google Scholar

26. Mayosi BM, Lawn JE, van Niekerk A, Bradshaw D, Abdool Karim SS, Coovadia HM. Health in South Africa: changes and challenges since 2009. Lancet 2012;380:2029–43.10.1016/S0140-6736(12)61814-5Search in Google Scholar

27. Hardy B-J, Séguin B, Ramesar R, Singer PA, Daar AS. South Africa: from species cradle to genomic applications. Nat Rev Genet 2008;9:S19–23.10.1038/nrg2441Search in Google Scholar PubMed

28. May A, Hazelhurst S, Li Y, Norris SA, Govind N, Tikly M, et al. Genetic diversity in black South Africans from Soweto. BMC Genomics 2013;14:644.10.1186/1471-2164-14-644Search in Google Scholar PubMed PubMed Central

29. Drögemöller BI, Wright GE, Niehaus DJ, Koen L, Malan S, Da Silva DM, et al. Characterization of the genetic profile of CYP2C19 in two South African populations. Pharmacogenomics 2010;11:1095–103.10.2217/pgs.10.90Search in Google Scholar PubMed

30. Ikediobi O, Aouizerat B, Xiao Y, Gandhi M, Gebhardt S, Warnich L. Analysis of pharmacogenetic traits in two distinct South African populations. Human Genomics 2011;5:265–82.10.1186/1479-7364-5-4-265Search in Google Scholar PubMed PubMed Central

31. Leat N, Benjeddou M, Davison S. Nine-locus Y-chromosome STR profiling of Caucasian and Xhosa populations from Cape Town, South Africa. Forensic Sci Int 2004;144:73–5.10.1016/j.forsciint.2004.02.022Search in Google Scholar PubMed

32. Flicek P, Amode MR, Barrell D, Beal K, Brent S, Carvalho-Silva D, et al. Ensembl 2012. Nucleic Acids Res 2012;40(D1):D84–90.10.1093/nar/gkr991Search in Google Scholar PubMed PubMed Central

33. Flanagan SE, Patch A-M, Ellard S. Using SIFT and PolyPhen to predict loss-of-function and gain-of-function mutations. Genet Test Mol Biomarkers 2010;14:533–7.10.1089/gtmb.2010.0036Search in Google Scholar PubMed

34. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009;4:1073–81.10.1038/nprot.2009.86Search in Google Scholar PubMed

35. Ng PC, Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 2003;31:3812–4.10.1093/nar/gkg509Search in Google Scholar PubMed PubMed Central

36. Kang H-J, Song I-S, Shin HJ, Kim W-Y, Lee C-H, Shim J-C, et al. Identification and functional characterization of genetic variants of human organic cation transporters in a Korean population. Drug Metab Dispos 2007;35:667–75.10.1124/dmd.106.013581Search in Google Scholar PubMed

37. Lazar A, Gründemann D, Berkels R, Taubert D, Zimmermann T, Schömig E. Genetic variability of the extraneuronal monoamine transporter EMT (SLC22A3). J Human Genetics 2003;48:226–30.10.1007/s10038-003-0015-5Search in Google Scholar PubMed

38. Leabman MK, Huang CC, DeYoung J, Carlson EJ, Taylor TR, de La Cruz M, et al. Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proc Natl Acad Sci USA 2003;100:5896–901.10.1073/pnas.0730857100Search in Google Scholar PubMed PubMed Central

39. Kajiwara M, Terada T, Ogasawara K, Iwano J, Katsura T, Fukatsu A, et al. Identification of multidrug and toxin extrusion (MATE1 and MATE2-K) variants with complete loss of transport activity. Human Genetics 2009;54:40–6.10.1038/jhg.2008.1Search in Google Scholar PubMed

40. Chen Y, Teranishi K, Li S, Yee SW, Hesselson S, Stryke D, et al. Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function. Pharmacogenomics J 2009;9:127–36.10.1038/tpj.2008.19Search in Google Scholar PubMed PubMed Central

41. Kajiwara M, Terada T, Asaka J-i, Ogasawara K, Katsura T, Ogawa O, et al. Critical roles of Sp1 in gene expression of human and rat H⁺/organic cation antiporter MATE1. Am J Physiol Renal Physiol 2007;293:F1564–70.10.1152/ajprenal.00322.2007Search in Google Scholar PubMed